Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Abrams

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|August 13, 2010
Inflammatory mediators may have divergent roles in cancer and in Alzheimer's diseaseR A Metz, B J Balin, J T Abrams, et al.
Blood|October 15, 1994
Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphomaS K Ghosh, J T Abrams, H Terunuma, et al.
Anesthesiology|November 20, 1997
Difficult or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cord closureJ A Bennett, J T Abrams, D F Van Riper, et al.
Transplantation|March 15, 1997
Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejectionK R Stone, A W Walgenbach, J T Abrams, et al.
Anesthesiology|December 1, 1991
Ventilatory compliance after three sufentanil-pancuronium induction sequencesJ C Horrow, J T Abrams, D F Van Riper, et al.
Anesthesia and Analgesia|August 10, 1999
Relief of chronic pain may be accompanied by an increase in a measure of heart rate variabilityR J Storella, Y Shi, D M O'Connor, et al.
Anesthesia and Analgesia|September 1, 1996
Upper airway closure: a primary source of difficult ventilation with sufentanil induction of anesthesiaJ T Abrams, J C Horrow, J A Bennett, et al.
Clinical and Diagnostic Laboratory Immunology|November 5, 1999
Sézary T-cell activating factor is a Chlamydia pneumoniae-associated proteinJ T Abrams, E C Vonderheid, S Kolbe, et al.
The British Veterinary Journal|November 1, 1970
Ocular changes associated with hypovitaminosis A in cattleK C Barnett, A C Palmer, J T Abrams, et al.
Journal of the American Academy of Dermatology|March 5, 1998
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphomaE C Vonderheid, Q Zhang, S R Lessin, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|August 13, 2010
Inflammatory mediators may have divergent roles in cancer and in Alzheimer's diseaseR A Metz, B J Balin, J T Abrams, et al.
Blood|October 15, 1994
Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphomaS K Ghosh, J T Abrams, H Terunuma, et al.
Anesthesiology|November 20, 1997
Difficult or impossible ventilation after sufentanil-induced anesthesia is caused primarily by vocal cord closureJ A Bennett, J T Abrams, D F Van Riper, et al.
Transplantation|March 15, 1997
Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejectionK R Stone, A W Walgenbach, J T Abrams, et al.
Anesthesiology|December 1, 1991
Ventilatory compliance after three sufentanil-pancuronium induction sequencesJ C Horrow, J T Abrams, D F Van Riper, et al.
Anesthesia and Analgesia|August 10, 1999
Relief of chronic pain may be accompanied by an increase in a measure of heart rate variabilityR J Storella, Y Shi, D M O'Connor, et al.
Anesthesia and Analgesia|September 1, 1996
Upper airway closure: a primary source of difficult ventilation with sufentanil induction of anesthesiaJ T Abrams, J C Horrow, J A Bennett, et al.
Clinical and Diagnostic Laboratory Immunology|November 5, 1999
Sézary T-cell activating factor is a Chlamydia pneumoniae-associated proteinJ T Abrams, E C Vonderheid, S Kolbe, et al.
The British Veterinary Journal|November 1, 1970
Ocular changes associated with hypovitaminosis A in cattleK C Barnett, A C Palmer, J T Abrams, et al.
Journal of the American Academy of Dermatology|March 5, 1998
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphomaE C Vonderheid, Q Zhang, S R Lessin, et al.
Pageof 3